产品编号：M296485
产品规格：500mg
产品价格：面议
| 标准品编号: | M296485 |
| 名称: | Methyl 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylate |
| 别名: | Methyl 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid Ester; Methyl 2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate Acetate; |
| CAS号: | 923942-34-1 |
| 分子式: | C₁₇H₁₈N₂O₃S |
| 外观: | 白色固体 |
| 熔点: | 157-159°C |
| 分子量: | 330.4 |
| 储存: | 冰箱 |
| 溶解度: | DMSO (Slightly), Methanol (Slightly) |
| 种类: | Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Methyl 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylate is a 4-Methylthiazole-5-carboxylic Acid derivative as a potential inhibitor of mucin onco proteins for breast cancer therapy. Also, it is derived from Febuxostat (F229000), which is a xanthine oxidase/xanthine dehydrogenase inhibitor and used for treatment of hyperuricemia and chronic gout. 40-120 mg/day febuxostat was proven effective in lowering serum urate levels when administered to manage hyperuricemia in patients with gout. |
| 参考文献 | |
